FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004031305> ?p ?o ?g. }

• W3004031305 endingPage "349" @default.
• W3004031305 startingPage "339" @default.
• W3004031305 abstract "Summary Background Acute atrial fibrillation is the most common arrythmia treated in the emergency department. Our primary aim was to compare conversion to sinus rhythm between pharmacological cardioversion followed by electrical cardioversion (drug–shock), and electrical cardioversion alone (shock-only). Our secondary aim was to compare the effectiveness of two pad positions for electrical cardioversion. Methods We did a partial factorial trial of two protocols for patients with acute atrial fibrillation at 11 academic hospital emergency departments in Canada. We enrolled adult patients with acute atrial fibrillation. Protocol 1 was a randomised, blinded, placebo-controlled comparison of attempted pharmacological cardioversion with intravenous procainamide (15 mg/kg over 30 min) followed by electrical cardioversion if necessary (up to three shocks, each of ≥200 J), and placebo infusion followed by electrical cardioversion. For patients having electrical cardioversion, we used Protocol 2, a randomised, open-label, nested comparison of anteroposterior versus anterolateral pad positions. Patients were randomly assigned (1:1, stratified by study site) for Protocol 1 by on-site research personnel using an online electronic data capture system. Randomisation for Protocol 2 occurred 30 min after drug infusion for patients who had not converted and was stratified by site and Protocol 1 allocation. Patients and all research and emergency department staff were masked to treatment allocation for Protocol 1. The primary outcome was conversion to normal sinus rhythm for at least 30 min at any time after randomisation and up to a point immediately after three shocks. Protocol 1 was analysed by intention to treat and Protocol 2 excluded patients who did not receive electrical cardioversion. This study is registered at ClinicalTrials.gov, number NCT01891058. Findings Between July 18, 2013, and Oct 17, 2018, we enrolled 396 patients, and none were lost to follow-up. In the drug–shock group (n=204), conversion to sinus rhythm occurred in 196 (96%) patients and in the shock-only group (n=192), conversion occurred in 176 (92%) patients (absolute difference 4%; 95% CI 0–9; p=0·07). The proportion of patients discharged home was 97% (n=198) versus 95% (n=183; p=0·60). 106 (52%) patients in the drug–shock group converted after drug infusion only. No patients had serious adverse events in follow-up. The different pad positions in Protocol 2 (n=244), had similar conversions to sinus rhythm (119 [94%] of 127 in anterolateral group vs 108 [92%] of 117 in anteroposterior group; p=0·68). Interpretation Both the drug–shock and shock-only strategies were highly effective, rapid, and safe in restoring sinus rhythm for patients in the emergency department with acute atrial fibrillation, avoiding the need for return to hospital. The drug infusion worked for about half of patients and avoided the resource intensive procedural sedation required for electrical cardioversion. We also found no significant difference between the anterolateral and anteroposterior pad positions for electrical cardioversion. Immediate rhythm control for patients in the emergency department with acute atrial fibrillation leads to excellent outcomes. Funding Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research." @default.
• W3004031305 created "2020-02-07" @default.
• W3004031305 creator A5009390781 @default.
• W3004031305 creator A5014602217 @default.
• W3004031305 creator A5018159014 @default.
• W3004031305 creator A5019610921 @default.
• W3004031305 creator A5022557025 @default.
• W3004031305 creator A5028252442 @default.
• W3004031305 creator A5035644440 @default.
• W3004031305 creator A5036139617 @default.
• W3004031305 creator A5038451924 @default.
• W3004031305 creator A5042214153 @default.
• W3004031305 creator A5045161959 @default.
• W3004031305 creator A5048426640 @default.
• W3004031305 creator A5052945297 @default.
• W3004031305 creator A5069162592 @default.
• W3004031305 creator A5069307903 @default.
• W3004031305 creator A5069563986 @default.
• W3004031305 creator A5070564381 @default.
• W3004031305 creator A5070731524 @default.
• W3004031305 creator A5073451344 @default.
• W3004031305 creator A5079801133 @default.
• W3004031305 creator A5089517417 @default.
• W3004031305 date "2020-02-01" @default.
• W3004031305 modified "2023-10-01" @default.
• W3004031305 title "Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial" @default.
• W3004031305 cites W100710028 @default.
• W3004031305 cites W1924174598 @default.
• W3004031305 cites W1979081635 @default.
• W3004031305 cites W1999199829 @default.
• W3004031305 cites W2003583202 @default.
• W3004031305 cites W2013311776 @default.
• W3004031305 cites W2016659665 @default.
• W3004031305 cites W2024407255 @default.
• W3004031305 cites W2025029346 @default.
• W3004031305 cites W2033952448 @default.
• W3004031305 cites W2053132213 @default.
• W3004031305 cites W2054167248 @default.
• W3004031305 cites W2066805338 @default.
• W3004031305 cites W2078129874 @default.
• W3004031305 cites W2079998884 @default.
• W3004031305 cites W2080280561 @default.
• W3004031305 cites W2100633958 @default.
• W3004031305 cites W2101791702 @default.
• W3004031305 cites W2102679841 @default.
• W3004031305 cites W2109627850 @default.
• W3004031305 cites W2121240867 @default.
• W3004031305 cites W2131080057 @default.
• W3004031305 cites W2147062790 @default.
• W3004031305 cites W2147131486 @default.
• W3004031305 cites W2164619372 @default.
• W3004031305 cites W2170797240 @default.
• W3004031305 cites W2397924561 @default.
• W3004031305 cites W2460196034 @default.
• W3004031305 cites W2575409261 @default.
• W3004031305 cites W2884040064 @default.
• W3004031305 cites W2912139642 @default.
• W3004031305 cites W2915092822 @default.
• W3004031305 cites W2921522488 @default.
• W3004031305 cites W3004050106 @default.
• W3004031305 cites W34600178 @default.
• W3004031305 cites W4239429542 @default.
• W3004031305 cites W47281674 @default.
• W3004031305 doi "https://doi.org/10.1016/s0140-6736(19)32994-0" @default.
• W3004031305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32007169" @default.
• W3004031305 hasPublicationYear "2020" @default.
• W3004031305 type Work @default.
• W3004031305 sameAs 3004031305 @default.
• W3004031305 citedByCount "53" @default.
• W3004031305 countsByYear W30040313052020 @default.
• W3004031305 countsByYear W30040313052021 @default.
• W3004031305 countsByYear W30040313052022 @default.
• W3004031305 countsByYear W30040313052023 @default.
• W3004031305 crossrefType "journal-article" @default.
• W3004031305 hasAuthorship W3004031305A5009390781 @default.
• W3004031305 hasAuthorship W3004031305A5014602217 @default.
• W3004031305 hasAuthorship W3004031305A5018159014 @default.
• W3004031305 hasAuthorship W3004031305A5019610921 @default.
• W3004031305 hasAuthorship W3004031305A5022557025 @default.
• W3004031305 hasAuthorship W3004031305A5028252442 @default.
• W3004031305 hasAuthorship W3004031305A5035644440 @default.
• W3004031305 hasAuthorship W3004031305A5036139617 @default.
• W3004031305 hasAuthorship W3004031305A5038451924 @default.
• W3004031305 hasAuthorship W3004031305A5042214153 @default.
• W3004031305 hasAuthorship W3004031305A5045161959 @default.
• W3004031305 hasAuthorship W3004031305A5048426640 @default.
• W3004031305 hasAuthorship W3004031305A5052945297 @default.
• W3004031305 hasAuthorship W3004031305A5069162592 @default.
• W3004031305 hasAuthorship W3004031305A5069307903 @default.
• W3004031305 hasAuthorship W3004031305A5069563986 @default.
• W3004031305 hasAuthorship W3004031305A5070564381 @default.
• W3004031305 hasAuthorship W3004031305A5070731524 @default.
• W3004031305 hasAuthorship W3004031305A5073451344 @default.
• W3004031305 hasAuthorship W3004031305A5079801133 @default.
• W3004031305 hasAuthorship W3004031305A5089517417 @default.
• W3004031305 hasConcept C118552586 @default.
• W3004031305 hasConcept C126322002 @default.
• W3004031305 hasConcept C164705383 @default.

• next